Zombie Infection Ltd

Zombie Infection Ltd
Statement of Financial Position
As at 31 May 2025

	Notes	31/05/2025 £	31/05/2024 £
Fixed assets
Tangible fixed assets	3	19,339	27,561
		19,339	27,561
Current assets
Debtors	4	6,773	2,441
Cash at bank and in hand		5,265	15,748
		12,038	18,189
Creditors: amount falling due within one year	5	(41,326)	(35,705)
Net current assets		(29,288)	(17,516)

Total assets less current liabilities		(9,949)	10,045
Creditors: amount falling due after more than one year	6	(9,989)	(10,823)
Accruals and deferred income		-	(274)
Provisions for liabilities	7	3,158	(387)
Net assets		(16,780)	(1,439)

Capital and reserves
Called up share capital		200	200
Profit and loss account		(16,980)	(1,639)
Shareholders' funds		(16,780)	(1,439)

For the year ended 31 May 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The financial statements were approved by the director on 22 October 2025 and were signed by:

-------------------------------
Gregory Stephen Rudman
Director

Zombie Infection Ltd
Notes to the Financial Statements
For the year ended 31 May 2025

General Information

Zombie Infection Ltd is a private company, limited by shares, registered in UK, registration number 09036260, registration address 27 Old Gloucester Street, , London, WC1N 3AX.

The presentation currency is £ sterling.

Accounting policies

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Deferred taxation

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date.

Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Current and deferred tax assets and liabilities are not discounted.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and Machinery	25% Straight Line
Motor Vehicles	25% Straight Line
Fixtures and Fittings	20% Reducing Balance
Computer Equipment	25% Straight Line

Provisions

Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated.

2.	Employees Average number of employees during the year was 12 (2024 : 28).

Tangible fixed assets

Cost or valuation	Plant and Machinery	Motor Vehicles	Fixtures and Fittings	Computer Equipment	Total
	£	£	£	£	£
At 01 June 2024	8,308	29,384	3,150	6,444	47,286
Additions	-	-	-	-	-
Disposals	-	-	-	-	-
At 31 May 2025	8,308	29,384	3,150	6,444	47,286
Depreciation
At 01 June 2024	8,108	4,844	1,860	4,913	19,725
Charge for year	100	7,096	258	768	8,222
On disposals	-	-	-	-	-
At 31 May 2025	8,208	11,940	2,118	5,681	27,947
Net book values
Closing balance as at 31 May 2025	100	17,444	1,032	763	19,339
Opening balance as at 01 June 2024	200	24,540	1,290	1,531	27,561

Debtors: amounts falling due within one year

	31/05/2025 £	31/05/2024 £
Trade Debtors	120	694
Prepayments & Accrued Income	4,046	703
Other Debtors	2,532	969
Tax Recoverable	75	75
	6,773	2,441

Creditors: amount falling due within one year

	31/05/2025 £	31/05/2024 £
Trade Creditors	3,292	140
Bank Loans Less than 1 Year	10,003	10,003
Social Security and Other Taxes	2,708	5,469
Other Creditors	7,703	7,703
Wages & Salaries Control Account	2,872	-
Directors' Current Accounts	14,748	12,390
	41,326	35,705

Creditors: amount falling due after more than one year

	31/05/2025 £	31/05/2024 £
Bank Loan 1-2 years	9,989	10,003
Bank Loan 2-5 years	-	820
	9,989	10,823

Provisions for liabilities

	31/05/2025 £		31/05/2024 £
Deferred Tax	(3,158)		387
	(3,158)		387

Registered Number: 09036260
UK
ZOMBIE INFECTION LTD

Unaudited Financial Statements

Period of accounts Start date: 01 June 2024 End date: 31 May 2025